glp 1 shots cost Understanding GLP-1 Drugs: Cost, Safety, and Access in Context Weight-loss drug boom shifts costs

R., Levine, J., Gershon, S., Mallinger, A

Retrieved 2026-07-19

7 Subcutaneous semaglutide was approved in 2021 and 2022 as Wegovy for weight loss in patients 12 and older after the STEP1 trial showed patients who took subcutaneous semaglutide had a -14.9% body weight reduction (-15.3kg) compared to -2.4% (-2.6kg) with placebo after 68 weeks

Each plan covers the medication, physician consultation through Beluga Health's board-certified network across all 50 states, preparation at F&F Pharmacies Inc., shipping, and platform access

Employees want health plans to cover GLP-1s for diabetes and weight loss, and increased demand puts pressure on employers to remain competitive